Separation of Cyclerion Therapeutics and Cyclerion’s $175 Million Private Placement

Ropes & Gray represented Ironwood Pharmaceuticals, a GI-focused healthcare company, in connection with its tax-free spin-off of its soluble guanylate cyclase business, Cyclerion Therapeutics, Inc., and…